Uncategorized

Generalized Anxiety Disorder |18-65| Outpatient | Earn up to $1,983

Generalized Anxiety Disorder |18-65| Outpatient | Earn up to $1,983 Segal Trials is conducting an outpatient clinical research study investigating the efficacy, safety, and tolerability of a medication in those with Generalized Anxiety. Study Details •Men and women 18 years to 65 •Experiencing or diagnosed with moderate to severe General Anxiety Disorder •Have had an […]

Generalized Anxiety Disorder |18-65| Outpatient | Earn up to $1,983 Read More »

Major Depressive Disorder |21-65| Outpatient | Earn up to $2,275

Major Depressive Disorder |21-65| Outpatient | Earn up to $2,275 Segal Trials is currently conducting an outpatient Psychedelic clinical research study evaluating the safety and efficacy of an investigational medication based on psilocybin for patients with Depression. Participants may qualify if they are: Adults between 21 and 65 years old Diagnosed or experience symptoms of Depression

Major Depressive Disorder |21-65| Outpatient | Earn up to $2,275 Read More »

Binge Eating Disorder | 18-55 | Outpatient | Up to $1,300

Binge Eating Disorder | 18-55 | Outpatient | Up to $1,300 Segal Trials is currently conducting an outpatient clinical research study evaluating the safety and efficacy of an investigational medication for patients with Binge Eating Disorder Participants may qualify if they are: Between the ages of 18-55 Meets Binge Eating Disorder criteria Recurrent episodes of

Binge Eating Disorder | 18-55 | Outpatient | Up to $1,300 Read More »

Bipolar Depression |18-65| Outpatient | Earn up to $900

Bipolar Depression |18-65| Outpatient | Earn up to $900 Segal Trials is currently conducting an outpatient clinical research study evaluating the safety and efficacy of an investigational medication for patients with depressive episodes associated with Bipolar I or Bipolar II Disorder Participants may qualify if they are: Participants who qualify may receive:  

Bipolar Depression |18-65| Outpatient | Earn up to $900 Read More »